Stories

There is no shortage of conversation about what AI can do. Every day brings a new headline, a new capability, a new prediction about how work will change.

Novartis R&D leaders discuss how Novartis science, technology and strategy are shaping the next decade of innovation

The roots of Novartis reach back more than 250 years, to the chemical and scientific traditions that helped shape modern healthcare. Thirty years after its creation, a legacy of discovery and curiosity continues to guide its pursuit of new possibilities for patients.

Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.

Novartis partners with the Special Olympics to support neuro‑inclusion and build environments where everyone belongs.

Polly Cooper, Clinical Development Function Head, UK

Our innovations matter only when they reach the people who need them. Yet millions live with heart disease or cancer without knowing it or have limited access to care – especially those in low-income, rural or other hard-to-reach communities.

How shared decision-making can support living well from the start with chronic myeloid leukemia

The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.

A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.

Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.